Avalyn Pharma Inc. Common Stock
AVLN Real Time Price USDRecent trades of AVLN by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in AVLN holdings by institutional investors
Quarterly net insider trading by AVLN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$60,000 Jul 17, 2026 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$40,000 Jan 16, 2026 Issue: Medical/Disease Research/Clinical Labs Health Issues
Former government officials who have lobbied for AVLN
3 former government officials from 2 congressional offices at 1 lobbying firm have lobbied for AVLN, most recently Dec 15, 2025.
-
Maren Mcbride House New Counsel, Rep. Mollohan -
Richard Burr Senate New U.S. Senator
-
Margaret Martin Senate New Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr
AVLN Estimated quarterly lobbying spending
AVLN Revenue by Segment or Geography
New AVLN patent grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded to AVLN from public contracts
Recent insights relating to AVLN
Recent picks made for AVLN stock on CNBC
ETFs with the largest estimated holdings in AVLN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AVLN stock a Buy, Sell, or Hold?
- What is the price target for $AVLN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AVLN stock?
- Who owns the most shares of $AVLN stock?
- What funds own $AVLN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AVLN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.
- Address Boston, MA
- Market Cap 1.3 billion
- Employees 0
- Industrial Classification N/A
Avalyn Pharma Inc. Common Stock (AVLN) Historical Stock Prices
Avalyn Pharma Inc. Common Stock (AVLN) closed at $29.67 on September 23, 2026. Over the past year its adjusted close ranged from $25.68 to $39.25. Daily prices go back to April 30, 2026, 101 trading days in all.
- 1 month-21.28%
- 3 months-1.40%
- Year to date—
- 1 year—
- 3 years—
- 5 years—
- Max+0.61%
Quiver Premium charts AVLN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | 32.19 | 32.53 | 29.14 | 29.67 | 29.67 | 252,042 |
| Sep 22, 2026 | 31.94 | 33.18 | 31.00 | 32.45 | 32.45 | 233,277 |
| Sep 21, 2026 | 31.34 | 33.00 | 30.97 | 31.62 | 31.62 | 177,307 |
| Sep 18, 2026 | 33.15 | 34.04 | 31.18 | 31.52 | 31.52 | 664,783 |
| Sep 17, 2026 | 35.26 | 35.46 | 31.77 | 33.43 | 33.43 | 317,013 |
| Sep 16, 2026 | 34.38 | 35.20 | 34.09 | 34.71 | 34.71 | 244,455 |
| Sep 15, 2026 | 35.01 | 35.53 | 32.59 | 34.28 | 34.28 | 227,176 |
| Sep 14, 2026 | 33.40 | 36.42 | 33.40 | 34.98 | 34.98 | 494,139 |
| Sep 11, 2026 | 35.15 | 35.39 | 33.56 | 33.57 | 33.57 | 132,883 |
| Sep 10, 2026 | 35.26 | 36.18 | 34.22 | 34.67 | 34.67 | 129,054 |
| Sep 9, 2026 | 37.30 | 37.69 | 35.60 | 35.88 | 35.88 | 168,567 |
| Sep 8, 2026 | 37.15 | 38.70 | 36.81 | 37.62 | 37.62 | 302,175 |
| Sep 4, 2026 | 35.21 | 38.34 | 34.90 | 37.39 | 37.39 | 243,509 |
| Sep 3, 2026 | 35.85 | 36.34 | 34.37 | 35.44 | 35.44 | 150,941 |
| Sep 2, 2026 | 35.29 | 36.21 | 34.62 | 35.58 | 35.58 | 181,851 |
| Sep 1, 2026 | 34.63 | 35.82 | 34.31 | 35.28 | 35.28 | 183,577 |
| Aug 31, 2026 | 34.52 | 35.61 | 34.22 | 34.73 | 34.73 | 333,131 |
| Aug 28, 2026 | 36.45 | 36.45 | 34.37 | 34.69 | 34.69 | 202,893 |
| Aug 27, 2026 | 36.82 | 37.52 | 36.19 | 36.51 | 36.51 | 129,008 |
| Aug 26, 2026 | 38.02 | 38.37 | 36.39 | 37.04 | 37.04 | 142,601 |
| Aug 25, 2026 | 37.99 | 39.10 | 37.87 | 38.20 | 38.20 | 108,363 |
| Aug 24, 2026 | 38.49 | 38.95 | 36.63 | 37.69 | 37.69 | 158,377 |
| Aug 21, 2026 | 37.13 | 39.68 | 37.06 | 38.37 | 38.37 | 159,499 |
| Aug 20, 2026 | 38.65 | 39.57 | 36.70 | 37.13 | 37.13 | 179,276 |
| Aug 19, 2026 | 39.64 | 40.03 | 38.53 | 38.97 | 38.97 | 141,729 |
| Aug 18, 2026 | 38.25 | 40.17 | 36.17 | 38.86 | 38.86 | 194,791 |
| Aug 17, 2026 | 38.84 | 39.62 | 37.87 | 38.25 | 38.25 | 148,863 |
| Aug 14, 2026 | 36.80 | 39.48 | 35.07 | 39.25 | 39.25 | 193,374 |
| Aug 13, 2026 | 37.48 | 38.00 | 35.70 | 36.58 | 36.58 | 266,309 |
| Aug 12, 2026 | 36.44 | 39.99 | 35.30 | 37.38 | 37.38 | 378,237 |
| Aug 11, 2026 | 34.82 | 35.84 | 34.30 | 35.46 | 35.46 | 219,806 |
| Aug 10, 2026 | 34.13 | 35.20 | 32.84 | 34.56 | 34.56 | 145,076 |
| Aug 7, 2026 | 33.00 | 34.15 | 32.25 | 33.92 | 33.92 | 120,915 |
| Aug 6, 2026 | 32.20 | 33.28 | 31.38 | 32.70 | 32.70 | 122,725 |
| Aug 5, 2026 | 31.00 | 32.04 | 30.76 | 32.00 | 32.00 | 188,930 |
| Aug 4, 2026 | 28.46 | 31.49 | 28.05 | 30.73 | 30.73 | 176,668 |
| Aug 3, 2026 | 29.17 | 29.34 | 27.57 | 28.50 | 28.50 | 110,852 |
| Jul 31, 2026 | 29.50 | 29.50 | 27.92 | 28.79 | 28.79 | 126,781 |
| Jul 30, 2026 | 27.90 | 29.71 | 27.89 | 29.31 | 29.31 | 118,569 |
| Jul 29, 2026 | 28.20 | 28.44 | 27.00 | 28.10 | 28.10 | 112,287 |
| Jul 28, 2026 | 27.86 | 28.10 | 26.81 | 27.79 | 27.79 | 186,842 |
| Jul 27, 2026 | 28.25 | 29.10 | 27.43 | 27.62 | 27.62 | 193,541 |
| Jul 24, 2026 | 29.98 | 30.26 | 27.84 | 27.95 | 27.95 | 139,587 |
| Jul 23, 2026 | 28.37 | 29.92 | 28.37 | 29.73 | 29.73 | 281,812 |
| Jul 22, 2026 | 28.66 | 30.45 | 28.25 | 28.72 | 28.72 | 293,985 |
| Jul 21, 2026 | 28.38 | 29.14 | 28.01 | 29.03 | 29.03 | 307,466 |
| Jul 20, 2026 | 28.31 | 29.02 | 27.84 | 28.63 | 28.63 | 195,722 |
| Jul 17, 2026 | 25.25 | 29.27 | 24.90 | 28.30 | 28.30 | 364,051 |
| Jul 16, 2026 | 27.31 | 28.50 | 25.07 | 25.68 | 25.68 | 289,727 |
| Jul 15, 2026 | 28.48 | 28.90 | 27.29 | 27.40 | 27.40 | 232,141 |
| Jul 14, 2026 | 28.00 | 29.14 | 27.05 | 28.28 | 28.28 | 203,783 |
| Jul 13, 2026 | 28.17 | 28.70 | 26.92 | 27.84 | 27.84 | 247,500 |
| Jul 10, 2026 | 28.67 | 28.70 | 27.07 | 28.06 | 28.06 | 322,027 |
| Jul 9, 2026 | 28.95 | 29.41 | 28.36 | 28.92 | 28.92 | 228,660 |
| Jul 8, 2026 | 28.43 | 29.48 | 28.09 | 28.94 | 28.94 | 419,968 |
| Jul 7, 2026 | 28.27 | 29.19 | 27.33 | 28.42 | 28.42 | 406,256 |
| Jul 6, 2026 | 29.42 | 29.42 | 27.36 | 27.65 | 27.65 | 518,809 |
| Jul 2, 2026 | 30.14 | 31.07 | 28.57 | 29.73 | 29.73 | 582,507 |
| Jul 1, 2026 | 32.92 | 32.92 | 29.57 | 30.17 | 30.17 | 785,936 |
| Jun 30, 2026 | 31.27 | 33.32 | 30.21 | 32.92 | 32.92 | 540,854 |
| Jun 29, 2026 | 30.51 | 32.24 | 30.29 | 31.00 | 31.00 | 349,660 |
| Jun 26, 2026 | 28.71 | 31.61 | 27.41 | 30.71 | 30.71 | 2,402,478 |
| Jun 25, 2026 | 30.09 | 30.54 | 28.25 | 28.98 | 28.98 | 279,422 |
| Jun 24, 2026 | 32.10 | 33.22 | 29.80 | 30.09 | 30.09 | 217,075 |
| Jun 23, 2026 | 32.71 | 33.24 | 30.30 | 32.29 | 32.29 | 350,573 |
| Jun 22, 2026 | 31.71 | 33.19 | 30.27 | 32.97 | 32.97 | 503,896 |
| Jun 18, 2026 | 29.60 | 32.16 | 29.32 | 31.45 | 31.45 | 1,515,228 |
| Jun 17, 2026 | 28.02 | 31.14 | 28.00 | 29.31 | 29.31 | 543,613 |
| Jun 16, 2026 | 28.26 | 29.78 | 28.00 | 28.07 | 28.07 | 383,857 |
| Jun 15, 2026 | 30.69 | 32.19 | 28.37 | 28.75 | 28.75 | 275,599 |
| Jun 12, 2026 | 28.17 | 30.45 | 26.02 | 30.08 | 30.08 | 286,486 |
| Jun 11, 2026 | 28.25 | 28.95 | 27.60 | 28.07 | 28.07 | 199,621 |
| Jun 10, 2026 | 29.00 | 31.00 | 28.47 | 28.53 | 28.53 | 342,827 |
| Jun 9, 2026 | 28.19 | 29.41 | 27.25 | 28.67 | 28.67 | 200,671 |
| Jun 8, 2026 | 27.62 | 29.00 | 26.20 | 28.06 | 28.06 | 272,294 |
| Jun 5, 2026 | 27.19 | 29.51 | 25.77 | 27.06 | 27.06 | 327,006 |
| Jun 4, 2026 | 26.42 | 28.00 | 25.70 | 26.99 | 26.99 | 215,960 |
| Jun 3, 2026 | 25.72 | 27.23 | 24.15 | 26.40 | 26.40 | 206,361 |
| Jun 2, 2026 | 26.40 | 27.46 | 25.70 | 25.72 | 25.72 | 149,989 |
| Jun 1, 2026 | 28.25 | 28.88 | 25.69 | 26.66 | 26.66 | 155,785 |
| May 29, 2026 | 28.41 | 29.80 | 26.88 | 28.78 | 28.78 | 268,113 |
| May 28, 2026 | 26.99 | 29.74 | 26.99 | 28.39 | 28.39 | 394,974 |
| May 27, 2026 | 26.70 | 28.86 | 26.12 | 26.82 | 26.82 | 213,197 |
| May 26, 2026 | 29.68 | 29.80 | 26.32 | 26.70 | 26.70 | 367,898 |
| May 22, 2026 | 28.45 | 29.67 | 26.68 | 28.84 | 28.84 | 321,470 |
| May 21, 2026 | 27.61 | 28.61 | 26.68 | 28.41 | 28.41 | 240,534 |
| May 20, 2026 | 26.63 | 28.50 | 26.01 | 28.03 | 28.03 | 181,017 |
| May 19, 2026 | 26.75 | 28.61 | 26.00 | 28.11 | 28.11 | 126,126 |
| May 18, 2026 | 29.52 | 29.80 | 25.21 | 26.63 | 26.63 | 430,257 |
| May 15, 2026 | 29.69 | 31.00 | 28.00 | 29.84 | 29.84 | 205,029 |
| May 14, 2026 | 30.77 | 31.34 | 28.80 | 30.62 | 30.62 | 178,226 |
| May 13, 2026 | 29.92 | 32.23 | 28.36 | 30.83 | 30.83 | 402,327 |
| May 12, 2026 | 29.27 | 31.02 | 29.25 | 29.90 | 29.90 | 308,642 |
| May 11, 2026 | 27.28 | 30.43 | 27.27 | 29.57 | 29.57 | 306,734 |
| May 8, 2026 | 26.66 | 29.00 | 26.64 | 27.33 | 27.33 | 290,423 |
| May 7, 2026 | 27.43 | 27.50 | 25.39 | 26.93 | 26.93 | 664,375 |
| May 6, 2026 | 27.16 | 27.73 | 25.05 | 27.71 | 27.71 | 673,816 |
| May 5, 2026 | 29.32 | 29.64 | 25.44 | 27.43 | 27.43 | 467,970 |
| May 4, 2026 | 30.14 | 30.67 | 28.01 | 29.07 | 29.07 | 357,303 |
| May 1, 2026 | 28.00 | 30.00 | 27.50 | 29.84 | 29.84 | 830,047 |
| Apr 30, 2026 | 26.00 | 30.20 | 26.00 | 29.49 | 29.49 | 6,511,988 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at AVLN, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|